|
Delayed
Toronto S.E.
06:30:09 05/11/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 4.240 CAD | +0.24% |
|
-7.02% | -12.03% |
| 04/11 | HLS Partners With Bayer to Sell Heart Failure Medication in Canada | MT |
| 01/10 | HLS Therapeutics Inc. Announces Board and Committee Changes | CI |
| Market Cap | 92M 81.98M 75.18M 68.33M 128M 8.69B 131M 899M 360M 4.6B 345M 338M 14.58B | P/E 2026 * |
-14.6x | P/E 2027 * | -43.2x |
|---|---|---|---|---|---|
| Enterprise Value | 92M 81.98M 75.18M 68.33M 128M 8.69B 131M 899M 360M 4.6B 345M 338M 14.58B | EV / Sales 2026 * |
1.58x | EV / Sales 2027 * | 1.41x |
| Free-Float |
99.44% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Toronto S.E.
| HLS | Delayed | |
Deutsche Boerse AG
| 74D | Delayed |
Last Transcript: HLS Therapeutics Inc.
| 1 day | +0.24% | ||
| 1 week | -7.02% | ||
| Current month | -5.99% | ||
| 1 month | +0.71% | ||
| 3 months | +2.91% | ||
| 6 months | -9.98% | ||
| Current year | -12.03% |
| 1 week | 4.2 |  | 4.69 |
| 1 month | 3.9 | | 4.69 |
| Current year | 3.56 | | 5.25 |
| 1 year | 3.56 | | 5.44 |
| 3 years | 3 | | 5.76 |
| 5 years | 3 | | 18.9 |
| 10 years | 3 | | 25.92 |
| Manager | Title | Age | Since |
|---|---|---|---|
Craig Millian
CEO | Chief Executive Officer | 58 | 01/05/2023 |
John Hanna
DFI | Director of Finance/CFO | 61 | 26/01/2024 |
Jason Gross
CTO | Chief Tech/Sci/R&D Officer | 61 | 01/06/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
Rodney Hill
BRD | Director/Board Member | 58 | 12/03/2018 |
John Welborn
CHM | Chairman | 48 | 22/06/2023 |
Norma Beauchamp
BRD | Director/Board Member | 65 | 01/01/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 30/9/26 | Tax | Company | 1,000 | 0.0032% | - | |
| 30/9/26 | Tax | Company | -1,000 | 0.0032% | - | |
| 29/9/26 | Tax | Company | 2,000 | 0.0065% | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.24% | -7.02% | -21.77% | -12.58% | 92M | |
| +0.73% | +10.38% | +56.81% | +138.92% | 1,255B | |
| +3.60% | +1.62% | +47.40% | +81.56% | 641B | |
| +2.09% | +2.08% | +35.23% | +106.76% | 505B | |
| +1.25% | -0.73% | +49.96% | +66.94% | 381B | |
| +2.62% | +5.39% | +77.10% | +42.34% | 357B | |
| +2.10% | +3.90% | +32.30% | +59.38% | 303B | |
| +1.92% | +9.87% | +11.94% | +36.47% | 286B | |
| +3.42% | +5.76% | +61.06% | +75.15% | 249B | |
| +4.19% | +9.93% | +42.28% | +115.68% | 208B | |
| Average | +2.06% | +1.91% | +39.23% | +71.06% | 418.53B | |
| Weighted average by Cap. | +1.93% | +3.90% | +48.56% | +93.75% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 58.34M 51.99M 47.67M 43.32M 81.45M 5.51B 83.31M 570M 228M 2.92B 219M 214M 9.24B | 65.06M 57.97M 53.17M 48.32M 90.83M 6.15B 92.9M 635M 255M 3.25B 244M 239M 10.31B |
| Net income | -5.47M -4.87M -4.47M -4.06M -7.64M -517M -7.81M -53.42M -21.42M -274M -20.53M -20.09M -867M | -2.16M -1.93M -1.77M -1.61M -3.02M -205M -3.09M -21.14M -8.47M -108M -8.12M -7.95M -343M |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/11/26 | CAD 4.240 | +0.24% | 20,373 |
| 03/11/26 | CAD 4.230 | -5.37% | 56,660 |
| 02/11/26 | CAD 4.470 | -0.89% | 10,905 |
| 30/10/26 | CAD 4.510 | -1.10% | 35,743 |
| 29/10/26 | CAD 4.560 | 0.00% | 158,109 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HLS Stock
Select your edition
All financial news and data tailored to specific country editions
